Trials / Not Yet Recruiting
Not Yet RecruitingNCT07476157
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-118 Compared to AD-1181 in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-118, AD-1181 | Single-dose oral administration of AD-118 or AD-1181, according to randomized sequence. |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2026-03-17
- Last updated
- 2026-03-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07476157. Inclusion in this directory is not an endorsement.